Monitoring Keap1-Nrf2 interactions in single live cells

Biotechnology Advances

Volumn 32, Issue 6, 2014, Pages 1133-1144

  Baird, Liam ^a,d   Swift, Sam ^a   Llères, David ^b   Dinkova Kostova, Albena T ^a,c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytoprotective enzymes; FLIM; FRET; Keap1; Nrf2; Sulforaphane

Indexed keywords

AMINO ACIDS; ENERGY TRANSFER; FLUORESCENCE IMAGING; FORSTER RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION; PLANTS (BOTANY); PROTEINS;

CRUCIFEROUS VEGETABLES; FLIM; KEAP1; MULTIPHOTON FLUORESCENCE; NF-E2 P45-RELATED FACTOR 2; NRF2; PHYSIOLOGICAL CONDITION; SULFORAPHANE;

TRANSCRIPTION;

KEAP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR NF E2 P45 SUBUNIT;

ANIMAL; BINDING SITE; CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; MOUSE; PROCEDURES; RAT; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS;

ANIMALS; BINDING SITES; CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; RATS; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS;

EID: 84918811379     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.03.004     Document Type: Review

References (121)

1. Abazeed M.E., Adams D.J., Hurov K.E., Tamayo P., Creighton C.J., Sonkin D., et al. Integrative radiogenomic profiling of squamous cell lung cancer. Cancer Res 2013, 73:6289-6298.
2. Adam J., Hatipoglu E., O'Flaherty L., Ternette N., Sahgal N., Lockstone H., et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011, 20:524-537.
3. Ahn Y.H., Hwang Y., Liu H., Wang X.J., Zhang Y., Stephenson K.K., et al. Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc Natl Acad Sci U S A 2010, 107:9590-9595.
4. Bae S.H., Sung S.H., Oh S.Y., Lim J.M., Lee S.K., Park Y.N., et al. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab 2013, 17:73-84.
5. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 2011, 85:241-272.
6. Baird L., Dinkova-Kostova A.T. Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells. Biochem Biophys Res Commun 2013, 433:58-65.
7. Baird L., Lleres D., Swift S., Dinkova-Kostova A.T. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A 2013, 110:15259-15264.
8. Batisse J., Guerrero S.X., Bernacchi S., Richert L., Godet J., Goldschmidt V., et al. APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells. J Virol 2013, 87:6492-6506.
9. Becker W. Fluorescence lifetime imaging - techniques and applications. J Microsc 2012, 247:119-136.
10. Borst J.W., Visser A.J. Fluorescence lifetime imaging microscopy in life sciences. Meas Sci Technol 2010, 21:102002.
11. Camp N.D., James R.G., Dawson D.W., Yan F., Davison J.M., Houck S.A., et al. Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein. J Biol Chem 2012, 287:6539-6550.
12. Chen W., Sun Z., Wang X.J., Jiang T., Huang Z., Fang D., et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009, 34:663-673.
13. Chowdhry S., Zhang Y., McMahon M., Sutherland C., Cuadrado A., Hayes J.D. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2013, 32:3765-3781.
14. Chusainow J., Ajuh P.M., Trinkle-Mulcahy L., Sleeman J.E., Ellenberg J., Lamond A.I. FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35. RNA 2005, 11:1201-1214.
15. Clegg R.M. Fluorescence resonance energy transfer. Fluorescence Imaging Spectroscopy and Microscopy 1996, 179-251. John Wiley & Sons. X.F. Wang, B. Herman (Eds.).
16. Comprehensive genomic characterization of squamous cell lung cancers Nature 2012, 489:519-525.
17. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004, 24:8477-8486.
18. Dawson J.P., Berger M.B., Lin C.C., Schlessinger J., Lemmon M.A., Ferguson K.M. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol 2005, 25:7734-7742.
19. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
20. Dinkova-Kostova A.T. Chemoprotection against cancer by isothiocyanates: a focus on the animal models and the protective mechanisms. Top Curr Chem 2013, 329:179-201.
21. Dinkova-Kostova A.T., Kostov R.V. Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 2012, 18:337-347.
22. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 2002, 99:11908-11913.
23. Dinkova-Kostova A.T., Holtzclaw W.D., Wakabayashi N. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 2005, 44:6889-6899.
24. Eades G., Yang M., Yao Y., Zhang Y., Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011, 286:40725-40733.
25. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., Mesecar A.D. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci U S A 2005, 102:10070-10075.
26. Eggler A.L., Luo Y., van Breemen R.B., Mesecar A.D. Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent. Chem Res Toxicol 2007, 20:1878-1884.
27. Eggler A.L., Small E., Hannink M., Mesecar A.D. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem J 2009, 422:171-180.
28. Ellis J.D., Lleres D., Denegri M., Lamond A.I., Caceres J.F. Spatial mapping of splicing factor complexes involved in exon and intron definition. J Cell Biol 2008, 181:921-934.
29. Ems-McClung S.C., Hainline S.G., Devare J., Zong H., Cai S., Carnes S.K., et al. Aurora B inhibits MCAK activity through a phosphoconformational switch that reduces microtubule association. Curr Biol 2013, 23:2491-2499.
30. Fahey J.W., Zalcmann A.T., Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001, 56:5-51.
31. Förster T. Delocalized excitation and excitation transfer. Modern Quantum Chemistry 1965, 93-137. Academic Press. O. Sinanoglu (Ed.).
32. 2 involves KEAP1 disulfide formation. J Biol Chem 2010, 285:8463-8471.
33. Fukutomi T., Takagi K., Mizushima T., Ohuchi N., Yamamoto M. Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1. Mol Cell Biol 2014, 34:832-846.
34. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012, 44:694-698.
35. Halkier B.A., Gershenzon J. Biology and biochemistry of glucosinolates. Annu Rev Plant Biol 2006, 57:303-333.
36. Hanada N., Takahata T., Zhou Q., Ye X., Sun R., Itoh J., et al. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 2012, 12:66.
37. Hancock R., Bertrand H.C., Tsujita T., Naz S., El-Bakry A., Laoruchupong J., et al. Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction. Free Radic Biol Med 2012, 52:444-451.
38. Hao B., Oehlmann S., Sowa M.E., Harper J.W., Pavletich N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007, 26:131-143.
39. Hast B.E., Goldfarb D., Mulvaney K.M., Hast M.A., Siesser P.F., Yan F., et al. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res 2013, 73:2199-2210.
40. Hast B.E., Cloer E.W., Goldfarb D., Li H., Siesser P.F., Yan F., et al. Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination. Cancer Res 2014, 74:808-817.
41. Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 2010, 13:1713-1748.
42. Herman B. Resonance energy transfer microscopy. Methods Cell Biol 1989, 30:219-243.
43. Hong F., Freeman M.L., Liebler D.C. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol 2005, 18:1917-1926.
44. Hong F., Sekhar K.R., Freeman M.L., Liebler D.C. Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J Biol Chem 2005, 280:31768-31775.
45. Hu C., Eggler A.L., Mesecar A.D., van Breemen R.B. Modification of keap1 cysteine residues by sulforaphane. Chem Res Toxicol 2011, 24:515-521.
46. Ichimura Y., Waguri S., Sou Y.S., Kageyama S., Hasegawa J., Ishimura R., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 2013, 51:618-631.
47. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997, 236:313-322.
48. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86.
49. Janes P.W., Wimmer-Kleikamp S.H., Frangakis A.S., Treble K., Griesshaber B., Sabet O., et al. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol 2009, 7:e1000215.
50. Karapetian R.N., Evstafieva A.G., Abaeva I.S., Chichkova N.V., Filonov G.S., Rubtsov Y.P., et al. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol 2005, 25:1089-1099.
51. Katoh Y., Itoh K., Yoshida E., Miyagishi M., Fukamizu A., Yamamoto M. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 2001, 6:857-868.
52. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007, 47:89-116.
53. Kim J.E., You D.J., Lee C., Ahn C., Seong J.Y., Hwang J.I. Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal 2010, 22:1645-1654.
54. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139.
55. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006, 26:221-229.
56. Komatsu M., Kurokawa H., Waguri S., Taguchi K., Kobayashi A., Ichimura Y., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010, 12:213-223.
57. Konstantinopoulos P.A., Spentzos D., Fountzilas E., Francoeur N., Sanisetty S., Grammatikos A.P., et al. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer. Cancer Res 2011, 71:5081-5089.
58. Kwak M.K., Itoh K., Yamamoto M., Kensler T.W. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002, 22:2883-2892.
59. Lakowicz J.R. Principles of fluorescence spectroscopy 2006, Springer. 3rd ed.
60. Lee D.F., Kuo H.P., Liu M., Chou C.K., Xia W., Du Y., et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol Cell 2009, 36:131-140.
61. Li W., Yu S.W., Kong A.N. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J Biol Chem 2006, 281:27251-27263.
62. Li H., Yu P., Sun Y., Felder R.A., Periasamy A., Jose P.A. Actin cytoskeleton-dependent Rab GTPase-regulated angiotensin type I receptor lysosomal degradation studied by fluorescence lifetime imaging microscopy. J Biomed Opt 2010, 15:056003.
63. Li Y., Paonessa J.D., Zhang Y. Mechanism of chemical activation of Nrf2. PLoS One 2012, 7:e35122.
64. Lichtman J.W., Conchello J.A. Fluorescence microscopy. Nat Methods 2005, 2:910-919.
65. Liu Y., Kern J.T., Walker J.R., Johnson J.A., Schultz P.G., Luesch H. A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci U S A 2007, 104:5205-5210.
66. Llères D., Swift S., Lamond A.I. Detecting protein-protein interactions in vivo with FRET using multiphoton fluorescence lifetime imaging microscopy (FLIM). Current protocols in cytometry 2007, [Chapter 12:Unit12 0]. J.P. Robinson (Ed.).
67. Lo S.C., Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 2006, 281:37893-37903.
68. Lo S.C., Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp Cell Res 2008, 314:1789-1803.
69. Ma J., Cai H., Wu T., Sobhian B., Huo Y., Alcivar A., et al. PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol Cell Biol 2012, 32:1506-1517.
70. Malhotra D., Portales-Casamar E., Singh A., Srivastava S., Arenillas D., Happel C., et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 2010, 38:5718-5734.
71. Marianayagam N.J., Sunde M., Matthews J.M. The power of two: protein dimerization in biology. Trends Biochem Sci 2004, 29:618-625.
72. Martinez V.D., Vucic E.A., Thu K.L., Pikor L.A., Lam S., Lam W.L. Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer. Head Neck 2014, [in press].
73. Matusheski N.V., Jeffery E.H. Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J Agric Food Chem 2001, 49:5743-5749.
74. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001, 61:3299-3307.
75. McMahon M., Thomas N., Itoh K., Yamamoto M., Hayes J.D. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 2004, 279:31556-31567.
76. McMahon M., Thomas N., Itoh K., Yamamoto M., Hayes J.D. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem 2006, 281:24756-24768.
77. McMahon M., Lamont D.J., Beattie K.A., Hayes J.D. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci U S A 2010, 107:18838-18843.
78. Mi L., Di Pasqua A.J., Chung F.L. Proteins as binding targets of isothiocyanates in cancer prevention. Carcinogenesis 2011, 32:1405-1413.
79. Mitsuishi Y., Motohashi H., Yamamoto M. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front oncol 2012, 2:200.
80. Mitsuishi Y., Taguchi K., Kawatani Y., Shibata T., Nukiwa T., Aburatani H., et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012, 22:66-79.
81. Munday R., Munday C.M. Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J Agric Food Chem 2004, 52:1867-1871.
82. Muscarella L.A., Barbano R., D'Angelo V., Copetti M., Coco M., Balsamo T., et al. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics 2011, 6:317-325.
83. Nioi P., Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun 2007, 362:816-821.
84. Nioi P., Nguyen T., Sherratt P.J., Pickett C.B. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol 2005, 25:10895-10906.
85. Ooi A., Wong J.C., Petillo D., Roossien D., Perrier-Trudova V., Whitten D., et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 2011, 20:511-523.
86. Ooi A., Dykema K., Ansari A., Petillo D., Snider J., Kahnoski R., et al. CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma. Cancer Res 2013, 73:2044-2051.
87. Padmanabhan B., Nakamura Y., Yokoyama S. Structural analysis of the complex of Keap1 with a prothymosin alpha peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008, 64:233-238.
88. Piston D.W., Kremers G.J. Fluorescent protein FRET: the good, the bad and the ugly. Trends Biochem Sci 2007, 32:407-414.
89. Prochaska H.J., Santamaria A.B.., Talalay P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci U S A 1992, 89:2394-2398.
90. Rada P., Rojo A.I., Evrard-Todeschi N., Innamorato N.G., Cotte A., Jaworski T., et al. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis. Mol Cell Biol 2012, 32:3486-3499.
91. Sato Y., Yoshizato T., Shiraishi Y., Maekawa S., Okuno Y., Kamura T., et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 2013, 45:860-867.
92. Schaap M1., Hancock R., Wilderspin A., Wells G. Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interaction. Protein Sci 2013, 22:1812-1819.
93. Sekar R.B., Periasamy A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J Cell Biol 2003, 160:629-633.
94. Sekhar K.R., Soltaninassab S.R., Borrelli M.J., Xu Z.Q., Meredith M.J., Domann F.E., et al. Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for gamma-glutamylcysteine synthetase. Biochem Biophys Res Commun 2000, 270:311-317.
95. Shay K.P., Michels A.J., Li W., Kong A.N., Hagen T.M. Cap-independent Nrf2 translation is part of a lipoic acid-stimulated detoxification stress response. Biochim Biophys Acta 2012, 1823:1102-1109.
96. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008, 135:1358-1368.
97. Shibata T., Ohta T., Tong K.I., Kokubu A., Odogawa R., Tsuta K., et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A 2008, 105:13568-13573.
98. Shibata T., Kokubu A., Saito S., Narisawa-Saito M., Sasaki H., Aoyagi K., et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 2011, 13:864-873.
99. Singh A., Happel C., Manna S.K., Acquaah-Mensah G., Carrerero J., Kumar S., et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest 2013, 123:2921-2934.
100. Solis L.M., Behrens C., Dong W., Suraokar M., Ozburn N.C., Moran C.A., et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 2010, 16:3743-3753.
101. Stephens D.J., Allan V.J. Light microscopy techniques for live cell imaging. Science 2003, 300:82-86.
102. Suzuki T., Shibata T., Takaya K., Shiraishi K., Kohno T., Kunitoh H., et al. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol Cell Biol 2013, 33:2402-2412.
103. Swift S.R., Trinkle-Mulcahy L. Basic principles of FRAP, FLIM and FRET. Proc R Microsc Soc 2004, 39:3-10.
104. Taguchi K., Fujikawa N., Komatsu M., Ishii T., Unno M., Akaike T., et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A 2012, 109:13561-13566.
105. Talalay P., Fahey J.W. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 2001, 131:3027S-3033S.
106. Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 2006, 387:1311-1320.
107. Tong K.I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 2006, 26:2887-2900.
108. Tong K.I., Padmanabhan B., Kobayashi A., Shang C., Hirotsu Y., Yokoyama S., et al. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol Cell Biol 2007, 27:7511-7521.
109. Wang R., An J., Ji F., Jiao H., Sun H., Zhou D. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem Biophys Res Commun 2008, 373:151-154.
110. Wang H., Liu K., Geng M., Gao P., Wu X., Hai Y., et al. RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res 2013, 73:3097-3108.
111. Welcker M., Clurman B.E. Fbw7/hCDC4 dimerization regulates its substrate interactions. Cell Div 2007, 2:7.
112. Yasuda R. Imaging spatiotemporal dynamics of neuronal signaling using fluorescence resonance energy transfer and fluorescence lifetime imaging microscopy. Curr Opin Neurobiol 2006, 16:551-561.
113. Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013, 45:1134-1140.
114. Zhang Y. The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. Carcinogenesis 2012, 33:2-9.
115. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003, 23:8137-8151.
116. Zhang Y., Talalay P., Cho C.G., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 1992, 89:2399-2403.
117. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci U S A 1994, 91:3147-3150.
118. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004, 24:10941-10953.
119. Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 2005, 280:30091-30099.
120. Zhang Y., Munday R., Jobson H.E., Munday C.M., Lister C., Wilson P., et al. Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem 2006, 54:9370-9376.
121. Zhang P., Singh A., Yegnasubramanian S., Esopi D., Kombairaju P., Bodas M., et al. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther 2010, 9:336-346.